InvestorsHub Logo
Post# of 252650
Next 10
Followers 831
Posts 120092
Boards Moderated 16
Alias Born 09/05/2002

Re: ciotera post# 240624

Wednesday, 01/12/2022 10:20:02 AM

Wednesday, January 12, 2022 10:20:02 AM

Post# of 252650
ABBV still asserts that Rinvoq+Skyrizi peak sales will be >100% of peak Humira sales; specifically, ABBV projects >=$7.5B of 2025 sales for each of Rinvoq and Skyrizi. See slide #7 below, which breaks down the projections by indication:

https://investors.abbvie.com/static-files/6eaf137c-4bee-4a5d-8047-33b9f299382d (slide #7)

Does anyone actually believe these numbers?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.